Artificial Blood Substitutes vs. Allogeneic Blood: Current Status
Artificial oxygen carriers (blood substitutes) are not standard of care. Allogeneic human blood transfusion remains the only widely available, regulated therapy for significant anemia/acute blood loss.
Categories of Blood Substitutes
- Hemoglobin-Based Oxygen Carriers (HBOCs): Cell-free hemoglobin (bovine, human, recombinant) — polymerized, cross-linked, encapsulated. Examples: Hemopure (HbO₂ Therapeutics — approved in SA for acute anemia), PolyHeme, Hemolink, OxyVita. None FDA-approved for general use. Toxicity: NO scavenging → vasoconstriction, hypertension, MI, stroke; oxidative injury; short half-life (12–24 hrs).
- Perfluorocarbon (PFC) Emulsions: Oxygen dissolves in PFC (Oxygent, Fluosol). No hemoglobin. Require high FiO₂. Limited O₂ capacity. Fluosol withdrawn; Oxygent failed Phase III.
- Stem Cell-Derived RBCs: In clinical trials (RESTORE trial, UK) — not yet commercial.
Current Clinical Use
- Jehovah's Witness patients refusing blood — compassionate use / clinical trial access.
- Military / remote / disaster settings — logistical advantages (storage, typing).
- Organ preservation (perfusion solutions).
Why Not Routine?
- Safety signals (HBOCs: increased mortality/MI in meta-analyses).
- Short duration (hours) vs. stored RBCs (42 days).
- No coagulation factors, platelets, immune modulators.
- Cost >> blood.
- Regulatory hurdles (FDA requires mortality benefit or non-inferiority + safety).
Research continues: PEGylated Hb, Hb vesicles, gene-edited universal RBCs. Blood conservation (PBM — patient blood management) is current standard to reduce transfusion need.
Blood Disorders - Related Articles
- Blood Python Pricing: Factors Influencing Cost and Average Ranges
- A History of Safe Blood Transfusions: From Landsteiner to Modern Practice
- Anemia Diagnosis & Treatment: Clinical Algorithm Guide
- Low Platelet Count (Thrombocytopenia): Causes, Symptoms & What to Expect
- Sepsis: Understanding, Symptoms, and Early Detection
- Sepsis-Induced Anemia: Mechanisms & Clinical Implications
- Understanding Prothrombin Time (PT) & INR: A Comprehensive Guide
